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ABSTRACT The sarcoplasmic reticulum (SR) Ca2 release channel (RyR1) from malignant hyperthermia-susceptible (MHS)
porcine skeletal muscle has a decreased sensitivity to inhibition by Mg2. This diminished Mg2 inhibition has been attributed
to a lower Mg2 affinity of the inhibition (I) site. To determine whether alterations in the Ca2 and Mg2 affinity of the activation
(A) site contribute to the altered Mg2 inhibition, we estimated the Ca2 and Mg2 affinities of the A- and I-sites of normal
and MHS RyR1. Compared with normal SR, MHS SR required less Ca2 to half-maximally activate [3H]ryanodine binding
(KA,Ca: MHS  0.17  0.01 M; normal  0.29  0.02 M) and more Ca
2 to half-maximally inhibit ryanodine binding (KI,Ca:
MHS  519.3  48.7 M; normal  293.3  24.2 M). The apparent Mg2 affinity constants of the MHS RyR1 A- and I-sites
were approximately twice those of the A- and I-sites of the normal RyR1 (KA,Mg: MHS  44.36  4.54 M; normal  21.59 
1.66 M; KI,Mg: MHS  660.8  53.0 M; normal  299.2  24.5 M). Thus, the reduced Mg
2 inhibition of the MHS RyR1
compared with the normal RyR1 is due to both an enhanced selectivity of the MHS RyR1 A-site for Ca2 over Mg2 and a
reduced Mg2 affinity of the I-site.
INTRODUCTION
Depolarization of the skeletal muscle plasma membrane
results in the spread of the action potential over the surface
and transverse-tubule membranes. Transverse-tubule depo-
larization effects a structural change in the dihydropyridine
receptor/L-type Ca2 channel that results in the release of
Ca2 from the sarcoplasmic reticulum (SR) via the high-
conductance Ca2 release channel/ryanodine receptor pro-
tein (RyR1). RyR1 is regulated in a complex fashion by
numerous endogenous effectors and, in the absence of other
modulators, is activated by Ca2 concentrations in the
nano- to micromolar range and inhibited by Ca2 concen-
trations in the micro- to millimolar range. Thus, it has been
concluded that the RyR1 has a high-affinity divalent bind-
ing site, which when occupied by Ca2 will activate the
channel (A-site), and a low-affinity divalent binding site,
which when occupied by Ca2 will inhibit the channel
(I-site) (Meissner, 1994).
RyR1 channel opening is inhibited by physiological con-
centrations of Mg2 (Endo, 1977; Meissner, 1994). Mg2
could potentially be a competitive antagonist at the A-site
on the RyR1, be an agonist at the I-site, or inhibit RyR1
channel opening via an independent inhibitory site. Laver et
al. (1997a) and Meissner et al. (1997) have suggested that
Mg2 inhibits RyR1 channel opening via its interaction
with both Ca2 binding sites and that the extent of the
interaction of Mg2 with the two regulatory sites depends
on the Ca2 concentration. Although the regulation of the
RyR1 by Ca2 and Mg2 has been extensively studied, and
the Ca2 affinity of the A- and I-sites estimated (Zucchi and
Ronca-Testoni, 1997; Meissner, 1994), the Mg2 affinity of
these sites has been reported only for frog RyRs (Murayama
et al., 2000). In addition, the apparent affinity of each of
these sites is dependent on the conditions under which the
measurements are made (Fruen et al., 1996; Meissner et al.,
1997). Thus, until the affinities of the two binding sites for
Ca2 and Mg2 are determined under identical conditions,
the potential physiological role of Mg2 at each site cannot
be concluded.
Malignant hyperthermia (MH) is a pharmacogenetic dis-
order originating primarily from mutations in the RyR1.
Although in the human population there are 24 known
RyR1 MH mutations (McCarthy et al., 2000; Jurkatt-Rott et
al., 2000), the primary defect in porcine MH is a single point
mutation (Arg6153Cys) in the RyR1 (Fujii et al., 1991).
RyR1 from MH-susceptible (MHS) individuals exhibits a
decreased sensitivity to inhibition by high concentrations of
Ca2 (Mickelson et al., 1988, 1990; Shomer et al., 1993;
Richter et al., 1997). A greater sensitivity to Ca2 activation
has also been reported (Shomer et al., 1993; Herrmann-
Frank et al., 1996; Richter et al., 1997). Although the Mg2
regulation of these channels also appears to be altered, most
studies have focused on the interaction of Mg2 with the
low-affinity I-site (Mickelson et al., 1990; Laver et al.,
1997a; Owen et al., 1997). In their comparison of RyR1
from normal and MHS pigs, Laver et al. (1997b) reported
that in the presence of 1 M Ca2, a Ca2 concentration
where they had previously found Mg2 inhibition via the A-
and I-sites to be equally important (Laver et al., 1997a), a
higher Mg2 concentration was required to half-maximally
inhibit MHS channels compared with normal channels. Al-
though the reported decrease in the Mg2 sensitivity of the
I-site contributed to the diminished Mg2 inhibition, the
possible involvement of the A-site, via an increased Ca2 or
decreased Mg2 affinity, cannot be excluded.
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The application of caffeine to skeletal muscle can trigger
SR Ca2 release and muscle contraction (Herrmann-Frank
et al., 1999). MHS skeletal muscle is more sensitive to
caffeine-induced contracture than skeletal muscle from nor-
mal individuals, and this enhanced caffeine sensitivity is
integral to the clinical diagnosis of MH (Jurkatt-Rott et al.,
2000). However, whether the MHS RyR1 itself is more
sensitive to caffeine remains controversial (Shomer et al.,
1994; Herrmann-Frank et al., 1996). Shomer et al. (1994)
reported that the MHS RyR1 is no more sensitive to caffeine
than the normal RyR1 and suggested that the increased
caffeine sensitivity of MHS muscle may be secondary to an
elevated resting myoplasmic Ca2 concentration or altered
Ca2 regulation of the RyR1. Although it has been reported
recently that the enhanced caffeine sensitivity of MHS
muscle is mediated by an increase in the resting myoplasmic
Ca2 concentration (Lopez et al., 2000), the effect of caf-
feine on the Ca2 and Mg2 affinities of the A- and I-sites
of the MHS and normal RyR1 have not been rigorously
examined.
We have now estimated the Ca2 and Mg2 affinities of
the normal and MHS RyR1 A- and I-sites under identical
conditions in the presence and absence of caffeine. Com-
pared with the normal RyR1, the MHS RyR1 I-site has a
lower apparent affinity for both Ca2 and Mg2. In con-
trast, compared with the normal RyR1, the MHS RyR1
A-site has a higher apparent affinity for Ca2 but a lower
apparent affinity for Mg2. In addition, caffeine increased
the Ca2 affinity of the MHS and normal RyR1 A-sites to
a similar extent. However, caffeine increased the Mg2
affinity of the normal RyR1 A-site but not of the MHS
RyR1 A-site. Thus, the MH mutation has opposite effects
on the Ca2 and Mg2 affinities of the RyR1 A-site that
would greatly enhance the sensitivity of the MHS RyR1 to
Ca2 activation in intact muscle.
MATERIALS AND METHODS
[3H]Ryanodine binding
Isolation of SR vesicles
Skeletal muscle SR vesicles were prepared from porcine longissimus dorsi
muscle as described previously (Mickelson et al., 1990). Briefly, muscle
was homogenized in 0.1 M NaCl, 5 mM Tris maleate buffer (pH 6.8), and
the membranes collected between 2,600 and 10,000  g were extracted in
0.6 M KCl, 20 mM Tris (pH 6.8), centrifuged at 100,000  g, and then
resuspended in 0.3 M sucrose, 0.1 M KCl, 5 mM Tris (pH 6.8) buffer; all
buffers contained a protease inhibitor mixture. SR vesicles were flash-
frozen in liquid nitrogen and stored at 70°C.
[3H]Ryanodine binding
SR vesicles (0.2 mg/ml) were incubated at 36°C in media containing 100
mM KCl, 10 mM HEPES, pH 7.4, 100 nM [3H]ryanodine, and a Ca-EGTA
buffer set to give the desired free Ca2 concentration (Brooks and Storey,
1992). In some experiments, the binding media also included 5 mM
caffeine. After 90 min, SR vesicles were collected on Whatman GF/B
filters and washed with 8 ml of ice-cold 100 mM KCl buffer. Estimates of
maximal [3H]ryanodine binding capacity of each SR vesicle preparation
were determined in media that in addition contained 500 mM KCl, 6 mM
ATP, and 10 M Ca2. Nonspecific binding was measured in the presence
of 20 M nonradioactive ryanodine. Binding experiments were performed
in duplicate using seven normal and nine MHS SR preparations.
Single-channel studies
The RyR1 was purified from SR membrane vesicles as described previ-
ously (Shomer et al., 1993). Muller-Rudin planar lipid bilayers were
formed by painting a lipid mixture (phosphatidylethanolamine, phosphati-
dylserine, and phosphatidylcholine in a 5:3:2 ratio by weight, 50 mg/ml
dissolved in n-decane) across a 250-m aperture in a Delrin cup. The cis
chamber was connected to the headstage input of an Axoclamp 200B patch
clamp amplifier (Axon Instruments, Foster City, CA). The trans chamber
was held at virtual ground. Data was filtered at 2 kHz with an eight-pole
Bessel filter, recorded at 4.5 kHz, and stored on a Jazz disk drive (Iomega,
Roy, UT). Recording solution consisted of symmetric 100 mM KCl, 10
mM HEPES, pH 7.4, 1 mM EGTA. The Mg2 and Ca2 concentrations
were adjusted by adding small aliquots of concentrated EGTA, CaCl2, and
MgCl2 (Brooks and Storey, 1992). Single-channel data were collected
using a pulsing protocol in which the potential was held at 0 mV for 4 s
between steps of 2-s duration to 70 mV (CLAMPEX program, pClamp
software, Axon Instruments, Foster City, CA). Only those channels that
had a conductance of at least 700 pS were used (Shomer et al., 1994).
Single-channel open probability (Po) was calculated from at least 50 2-s
sweeps using FETCHAN and PSTAT analysis programs (pClamp soft-
ware, Axon Instruments). When two channels were present in the bilayer,
indicated by current amplitudes of twice the expected magnitude, Po was
estimated as the average Po of the two channels, calculated as [Po,level 1 
(Po,level 2  2)]/2. Bilayers in which three channels had incorporated were
dealt with similarly; recordings were not made from bilayers containing
more than three channels.
Analysis
The Ca2 and Mg2 affinities of the A- and I-sites of RyR1 were estimated
according to the model of Murayama et al. (2000). The fraction of A-sites
bound with Ca2 (ƒA) and the fraction of I-sites not bound with Ca2 or
Mg2 (1  ƒI) were expressed as
fA Ca2nA,Ca/	Ca2nA,Ca KA,Ca
nA,Ca
 
1 Mg2nA,Mg/KA,Mg
nA,Mg  (1)
1 fI 1/
1 Ca2nI,Ca/K I,Ca
nI,Ca Mg2nI,Mg/K I,Mg
nA,Mg, (2)
where KA,Ca, KA,Mg, KI,Ca, and KI,Mg are the apparent affinity constants for
Ca2 and Mg2 of the A- and I-sites, respectively. nA,Ca, nA,Mg, nI,Ca, and
nI,Mg are the Hill coefficients for Ca2 and Mg2 of the A- and I-sites,
respectively.
The above parameters were determined in a three-step procedure. First,
KA,Ca, nA,Ca, KI,Ca, and nI,Ca were determined from the Ca2 dependence of
SR vesicle [3H]ryanodine binding (B) in the absence of Mg2 according to
Eq. 3:
B BpeakfA
1 fI
 Bpeak	Ca2nA,Ca/
Ca2nA,Ca KA,Ca
nA,Ca
 	1 Ca2nI,Ca/
Ca2nI,Ca K I,Ca
nI,Ca. (3)
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Bpeak in these equations indicates the maximal SR vesicle [3H]ryanodine
binding under the conditions of the experiment. Then, the concentration
dependence of Mg2 inhibition of SR vesicle [3H]ryanodine binding was
measured at a Ca2 concentration much greater than KA,Ca. At this Ca2
concentration, Ca2 is bound to the A-site and the inhibition by Mg2
occurs via the I-site. KI,Mg and nI,Mg were determined by fitting the data
from these experiments with Eq. 4 and including the values previously
obtained for KA,Ca,nA,Ca,KI,Ca,andnI,Ca:
B Bpeak
1 fI
 Bpeak	1/1 
Ca2nI,Ca/K I,Ca
nI,Ca Mg2nI,Mg/K I,Mg
nI,Mg.
(4)
Finally, the concentration dependence of Mg2 inhibition of SR vesicle
[3H]ryanodine binding was measured at a Ca2 concentration near KA,Ca.
At this Ca2 concentration, competitive inhibition by Mg2 at the A-site
predominates. KA,Mg and nA,Mg were determined by fitting the data from
these experiments with Eq. 5, using values previously obtained for KA,Ca,
nA,Ca, KI,Ca, nI,Ca, KI,Mg, and nI,Mg:
B Bpeak fA
1 fI
 Bpeak Ca2nA,CaCa2nA,Ca KA,CanA,Ca
1 Mg2nA,Mg/KA,MgnA,Mg 
 11 Ca2nI,CaK I,CanI,Ca  Mg
2nI,Mg
K I,Mg
nI,Mg . (5)
The model is depicted diagrammatically in Fig. 1 using parameters derived
in the presence of 1 mM Mg2. The Ca2 dependence of the fraction of
channels activated, i.e., SR vesicle [3H]ryanodine binding (solid line), is
the product of the fraction of channels with the A-site bound with Ca2 (fA,
dashed and dotted line) and the fraction of channels with the I-site free of
both Ca2 and Mg2 (1  fI, dashed line). As a competitive antagonist of
Ca2 for binding to the A-site, Mg2 effectively increases KA,Ca, shifts the
Ca2 dependence of fA to higher Ca2 concentrations, and increases the
Ca2 required for channel activation. Because Mg2 is an agonist at the
I-site, Mg2 will decrease the fraction of channels with the I-site free of
both Ca2 and Mg2, resulting in a reduction in the number of channels
available for activation. Thus, it is clear that the diagram is drawn as would
occur in the presence of a Mg2 concentration somewhat below the KI,Mg
(at very low Ca2 concentrations, 1  fI  0.5). It should be pointed out
that in the presence of Mg2, differences in the Ca2 dependence of MHS
and normal RyR1 channel activation could potentially occur via an in-
crease in the Ca2 affinity of the A-site, by a decrease in the Mg2 affinity
of the A-site, or both.
In an initial experiment, to determine whether MHS and normal RyR1s
differ in their sensitivities to inhibition by Mg2, the Mg2 concentration
dependence of MHS and normal SR [3H]ryanodine binding was compared
in the presence of 10 M Ca2. In this experiment the inhibitory effect of
Mg2 could not be attributed to its action at a single site. Therefore, the
half-inhibitory (IC50) concentrations were determined using the Hill equa-
tion. Curve fitting was performed using SigmaPlot 5.0 (SPSS, Richmond,
CA) software. All data are expressed as mean  SEM. Comparisons
between muscle types or treatments performed were made via two-sample
t-tests with the level of significance set at p  0.05.
RESULTS
The model used to estimate the Ca2 and Mg2 affinities of
the RyR1 A- and I-sites (Murayama et al., 2000) is depen-
dent on the assumption that Mg2 is a competitive inhibitor
with Ca2 at the A-site and is an agonist at the I-site. This
assumption was confirmed in single-channel studies (Fig.
2). Thus, if channels were activated by low concentrations
of Ca2 (near KA,Ca), the subsequent addition of a low
concentration of Mg2 should compete with Ca2 for the
A-site and decrease the mean single-channel percent open
time. Under these conditions, increasing concentrations of
Ca2 would effectively compete with Mg2 for the A-site
and increase the single-channel percent open time. As
shown in Fig. 2 A, a normal RyR1 channel activated by 300
nM cis Ca2 had a mean single-channel percent open time
of 4.19. The addition of 50 M Mg2 to the cis chamber
decreased the percent open time to 0.92. Increasing the
Ca2 concentration in the cis chamber to 3 M increased
the single-channel percent open time to 5.06. Similar results
were obtained in all six experiments, although the sensitiv-
ity of the channels to Ca2 and Mg2 varied (Fig. 2 C).
Thus, these single-channel experiments are consistent with
the hypothesis that Mg2 can act as a competitive antago-
nist with Ca2 at the A-site.
Single-channel studies also confirmed the assumption
that at Ca2 concentrations sufficient to saturate the A-site,
Mg2 interacts with the I-site. Thus, the single normal
channel in Fig. 2 B, activated by 300 M Ca2 had a mean
single-channel percent open time of 1.23. The addition of 50
MMg2 to the cis chamber lowered the percent open time
to 1.05. However, in contrast to experiments in 300 nM
Ca2, this channel could not be reactivated by the subse-
FIGURE 1 Diagrammatic representation of the model described in Ma-
terials and Methods used to derive the Ca2 and Mg2 affinities of the
RyR1 A- and I-sites. The Ca2 dependence of channel activation (——) is
the product of the fraction of channels with Ca2 bound to the A-site (fA,
—  —) and the fraction of channels with the I-site free of both Ca2 and
Mg2 (1-fI, — — —). Because Mg2 is a competitive antagonist with
Ca2 at the A-site, Mg2 will effectively increase the KA,Ca thereby
shifting the Ca2 dependence of channel activation to higher Ca2 con-
centrations. As an agonist at the I-site, Mg2 will decrease the fraction of
channels with the I-site free of Ca2 and Mg2 and thus decrease the
number of channels available for activation. Note that the parameters
illustrated were derived in the presence of 1 mM Mg2.
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quent addition of Ca2. Indeed, the additional 100 M
Ca2 added to the cis chamber further reduced the percent
open time to 0.51. Similar results were obtained with all six
experiments (Fig. 2 D). Although the extent of inhibition
was variable, in no case did increasing cis Ca2 increase the
percent open time of Mg2-inhibited channels. Thus, when
the Ca2 concentration is greater than that required to
maximally activate the RyR1 (i.e., when the A-site is in the
Ca2 bound state), Mg2 is an agonist at the low-affinity
I-site.
The maximal [3H]ryanodine binding (i.e., in 500 mM KCl,
10 M Ca2, and 6 mM ATP) for 9 normal (11.6  1.1
pmol/mg protein) and 11 MHS (9.5  0.8 pmol/mg protein)
SR preparations were not significantly different. Both MHS
and normal SR exhibited the characteristic bell-shaped Ca2
dependence of [3H]ryanodine binding. However, compared
with normal SR, MHS SR [3H]ryanodine binding was more
sensitive to Ca2 activation and less sensitive to inhibition by
Ca2 (Fig. 3). The KA,Ca, nA,Ca, KI,Ca, and nI,Ca of the RyR1
determined for both muscle types according to Eq. 3 are
presented in Table 1. TheMHSKA,Ca was significantly smaller
than the normal KA,Ca; in contrast, the MHS KI,Ca was more
than 1.7-fold greater than the normal KI,Ca. Thus, compared
with the normal RyR1, the MHS RyR1 A-site had a higher
apparent affinity for Ca2 whereas the I-site had a lower
apparent affinity for Ca2.
To determine whether the normal and MHS RyR1 also
differ in their sensitivity to Mg2 inhibition, the Mg2
FIGURE 2 Effects of Ca2 and Mg2 in combination on the single-channel activity of the RyR1. Single-channel activity of normal channels was
recorded as described in Materials and Methods. Recording solution contained 100 mM KCl, 10 mM HEPES (pH 7.4), 2 mM EGTA, and CaCl2 and MgCl2
to obtain the indicated ionized Ca2 and Mg2 concentrations. Single-channel currents were obtained with voltage steps from 0 mV to 70 mV. The solid
line indicates the closed state of the channels; openings are upward. (A) (a) Single channel activated by 300 nM cis Ca2. Percent open time (%OT) 
4.19, mean open time (OT)  1.0 ms, and mean closed time (CT)  8.4 ms; (b) Addition of 50 M cis Mg2 decreased the %OT to 0.92 (OT  0.9 ms,
CT  21.4 ms); (c) Increasing cis Ca2 to 3 M reactivated the channel (%OT  5.06, OT  1.2 ms, CT  8.8 ms). (B) (a) Single channel activated
by 300 M cis Ca2 (%OT  1.23, OT  1.0 ms, CT  16.6 ms); (b) Addition of 50 M cis Mg2 decreased %OT to 1.05 (OT  0.9 ms, CT  17.2
ms); (c) Increasing cis Ca2 to 400 M further decreased the %OT to 0.51 (OT  1.0 ms, CT  32.5 ms). Each color bar in C and D represents a different
experiment. In all experiments, the addition of 50 M Mg2 to the cis chamber reduced the mean single-channel percent open time when the free Ca2
concentration was either 300 nM, n  6 (C) or 300 M, n  6 (D). (C) When the Ca2 concentration was increased from 300 nM to 3 M in the presence
of Mg2, the %OT increased. (D) When the Ca2 concentration was increased from 300 M to 400 M in the presence of Mg2, the %OT decreased.
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dependence of SR vesicle [3H]ryanodine binding was de-
termined in the presence of 10 M Ca2, a Ca2 concen-
tration that is more than 30 times the KA,Ca. As shown in
Fig. 4, in the presence of 10 M Ca2 the concentration
dependence of Mg2 inhibition of [3H]ryanodine binding to
MHS SR was shifted to significantly higher Mg2 concen-
trations compared with that of normal SR. The IC50 values,
derived from the Hill equation, for MHS and normal SR
were 652.0  46.5 M and 304.9  49.6 M Mg2,
respectively. Thus, [3H]ryanodine binding to MHS SR ap-
pears to be less sensitive to inhibition by Mg2 than is
[3H]ryanodine binding to normal SR.
From the experiments described above, we conclude that
compared with the normal RyR1, the MHS RyR1 A-site has
a higher Ca2 affinity, the I-site has a lower Ca2 affinity,
and the MHS channels are less sensitive to inhibition by
Mg2. However, because Mg2 inhibition occurs via its
binding to both regulatory sites, and there are significant
differences in the Ca2 affinities of both sites, it is not
possible, from the data presented in Fig. 4, to identify the
mechanism responsible for the decreased inhibition of the
MHS RyR1 by Mg2. The MHS RyR1 I-site may have a
reduced Mg2 affinity as suggested by Laver et al. (1997b),
the MHS RYR1 A-site may have a reduced Mg2 affinity,
or both. Furthermore, an increased affinity of the MHS
RyR1 A-site for Ca2, with no change in the Mg2 affinity,
could also result in a decreased competitive inhibition of the
MHS RyR1 by Mg2. To distinguish between these possi-
bilities, we estimated the affinities of the normal and MHS
RyR1 A- and I-sites for Mg2.
We determined the Mg2 dependence of the inhibition of
[3H]ryanodine binding in the presence of 300 M Ca2, a
concentration of Ca2 that is 1000-fold greater than the
RyR1 KA,Ca (Table 1). At this Ca2 concentration the
FIGURE 3 Comparison of the Ca2 dependence of [3H]ryanodine bind-
ing to normal and MHS SR vesicles. [3H]Ryanodine binding to normal (E)
and MHS (F) skeletal muscle SR vesicles was determined as described in
Materials and Methods. Media contained 100 mM KCl, 10 mM HEPES
(pH 7.4), and Ca-EGTA buffer set to provide the indicated free Ca2
concentrations. Data are expressed as percentages of the maximal [3H]ry-
anodine binding capacity of the SR preparations. Solid lines are based on
fits to Eq. 3 (see Materials and Methods). Means  SEM are of seven
independent experiments performed in duplicate (seven different SR ves-
icle preparations).
FIGURE 4 Inhibition of [3H]ryanodine binding to normal and MHS SR
by Mg2. [3H]Ryanodine binding to normal (E) and MHS (F) skeletal
muscle SR vesicles was determined as described in Materials and Methods.
Media contained 100 mM KCl, 10 mM HEPES (pH 7.4), and 2 mM
EGTA. Ca2 and Mg2 concentrations were adjusted to maintain an
ionized Ca2 concentration of 10 M and various ionized Mg2 concen-
trations as indicated. Data are expressed as percentages of the maximal
[3H]ryanodine binding capacity of the SR vesicle preparations; solid lines
are based on fits to the Hill equation. Means  SEM are of five indepen-
dent experiments preformed in duplicate (five different SR vesicle prepa-
rations).
TABLE 1 Ca2 and Mg2 parameters for the activation and inhibition sites of normal and MHS RyR1
Ca2 parameters Mg2 parameters
KA,Ca (M) nA KI,Ca (M) nI KAMg (M) nA KIMg (M) nI
No caffeine
Normal 0.29  0.2 1.8  0.2 293.3  24.2 1.0  0.1 21.59  1.66 1.0  0.1 299.2  24.5 0.8  0.1
MHS 0.17  .01* 1.6  0.1 519.3  48.7* 1.3  0.1* 44.36  4.54* 1.2  0.1 660.8  53.0* 1.2  0.1
5 mM caffeine
Normal 0.071  .005† 2.1  0.3 376.1  45.8 1.2  0.1 5.59  1.28† 1.2  0.1 285.6  51.5 0.7  0.1
MHS 0.051  .003*† 1.3  0.1* 584.1  27.2* 1.3  0.1 50.45  1.93* 1.5  0.1*† 531.0  41.5* 1.1  0.1*
*Significantly different from normal, p  0.05.
†Significantly different from the absence of caffeine, p  0.05.
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A-sites should be fully occupied by Ca2, and inhibition of
[3H]ryanodine binding by Mg2 should occur primarily via
the I-site. Fitting this data with Eq. 4, using the previously
determined Ca2 affinities and Hill coefficients, allowed us
to estimate the Mg2 affinity of the I-sites of both MHS and
normal RyR1 (Fig. 5; Table 1). This analysis indicated that
the KI,Mg of the MHS RyR1 I-site was approximately twice
that of the normal RyR1 I-site. However, the relative Mg2/
Ca2 affinities for MHS and normal RyR1 were both 1
(Table 2), indicating the MHS mutation decreases the af-
finity of the I-site for both divalent ions in a similar fashion.
Next, we examined the concentration dependence of the
inhibition of SR [3H]ryanodine binding by Mg2 in the
presence of 300 nM Ca2, a Ca2 concentration near the
KA,Ca. At this Ca2 concentration, Mg2 will inhibit RyR1
channel opening primarily via its action at the RyR1 A-site.
Fitting these data in Fig. 5 with Eq. 5 provided values for
KA,Mg. As shown in Table 1, the MHS KA,Mg was approx-
imately twice the value for the normal RyR1. Consequently,
in contrast to its effect on the I-site, the MHS mutation
altered the apparent affinity of the A-site for Ca2 and
Mg2 in opposite ways, increasing the Ca2 affinity and
decreasing the Mg2 affinity. As a result, the selectivity of
the MHS RyR1 A-site for Ca2 over Mg2 was 3.5-fold
greater than the normal RyR1 A-site (Table 2).
If the model described in the methods and derived pa-
rameters in Table 1 are valid, it should be possible to predict
the Ca2 dependence of [3H]ryanodine binding to SR ves-
icles in the presence of various concentrations of Mg2.
Therefore, we determined the Ca2 dependence of ryano-
dine binding to normal and MHS SR vesicles in the pres-
ence of 100 M and 500 M Mg2 and fit the data
according to Eq. 5 using the parameters given in Table 1
(Fig. 6). If the conditions are established such that Mg2
inhibition occurs primarily as a result of its binding to the
A-site, a shift in the activation side of the Ca2 dependence
curve to higher Ca2 concentrations, with no change in the
inactivation side of the curve would be expected. Thus, 100
M Mg2, a Mg2 concentration near the KA,Mg increased
the Ca2 concentration required to activate normal and
MHS SR vesicle [3H]ryanodine binding compared with
experiments performed in the absence of Mg2. Half-acti-
vating Ca2 concentrations (EC50) of 0.50  0.03 M and
0.34  0.03 M were derived for normal and MHS SR,
respectively (compare with KA,Ca in Table 1). In contrast,
the Ca2 dependence of RyR1 inhibition was not signifi-
cantly altered in either muscle type. The IC50 values in the
presence of 100 M Mg2 were 344.7  22.6 M for
normal and 416.3  36.1 M for MHS SR (compare with
KI,Ca in Table 1). Thus, low concentrations of Mg2 (100
MMg2) affect [3H]ryanodine binding primarily via com-
petition with Ca2 for the A-site on the RyR1.
The lower-affinity I-site has a similar affinity for Ca2
and Mg2 (Table 1). Therefore, a Mg2 concentration near
the KI,Ca should inhibit ryanodine binding by acting at both
the A- and I-sites. Accordingly, 500 MMg2 shifted both
the Ca2 dependence of activation and decreased the max-
imal extent of Ca2 activation (Fig. 6). This concentration
FIGURE 5 Mg2 dependence of [3H]ryanodine binding to normal and
MHS SR in the presence of various concentrations of Ca2. [3H]Ryanodine
binding to normal (A) and MHS (B) skeletal muscle SR was determined as
described in Materials and Methods. Media contained 100 mM KCl, 10
mM HEPES (pH 7.4), and 2 mM EGTA. The concentrations of MgCl2 and
CaCl2 were adjusted to maintain the ionized Ca2 concentration of 300 nM
(F), 10 M (E), or 300 M () and Mg2 as indicated in the figure. Data
for 10 M Ca2 (E) are replotted from Fig. 3 for comparison with 300 nM
and 300 M Ca2. Data are expressed as percentages of the [3H]ryanodine
binding in the absence of Mg2; solid lines are based on fits to Eq. 5 (see
Materials and Methods). Means  SEM are of five independent experi-
ments preformed in duplicate (five different SR vesicle preparations).
TABLE 2 Relative Mg2 and Ca2 affinities of the activation
and inhibition sites of normal and MHS RyR1
No caffeine 5 mM caffeine
KA,Mg/KA,Ca KI,Mg/KIca KA,Mg/KA,Ca KI,Mg/KIca
Normal 74.5 1.0 78.7 0.8
MHS 260.9 1.3 989.2 0.9
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of Mg2 increased the Ca2 EC50 for both types of SR
(MHS: 5.86  1.06 M; normal: 6.36  1.32 M). Like-
wise, the Ca2 IC50 was also increased for both MHS
(740  8 M) and normal (630  13 M) SR.
The fitted lines in Fig. 6 derived from Eq. 5 and using the
parameters presented in Table 1 appear to fit the data well
and adequately describe the combined effects of Ca2 and
Mg2 on ryanodine binding to both MHS and normal SR.
Thus, the data presented in Fig. 6 support the validity of
both the model and the derived parameters.
Although MHS skeletal muscle fibers are more sensitive
to caffeine-induced contraction, Shomer et al. (1994) sug-
gested that an increased Ca2 sensitivity of the MHS RyR1
channel, rather than increased caffeine affinity, underlies
the greater responsiveness of MHS muscle to caffeine.
Therefore, we examined the effects of 5 mM caffeine on the
Ca2 and Mg2 affinities of the normal and MHS RyR1
A-and I-sites (Table 1). Caffeine did not significantly alter
the Ca2 or Mg2 affinity of the I-site of either the MHS or
normal RyR1. Caffeine had a similar effect on the MHS and
normal A-site Ca2 affinity, increasing the apparent affinity
approximately 3–4-fold. In contrast, caffeine had divergent
effects on the Mg2 affinity of the MHS and normal A-site.
The caffeine-induced increase in the Mg2 affinity (3.9-
fold) of the normal RyR1 A-site was similar to the increase
in the Ca2 affinity (4.1-fold). In contrast, caffeine did not
significantly increase the affinity of the MHS RyR1 A-site
for Mg2. Thus, 5 mM caffeine increased the Ca2 affinity
of the A-site of both channel types to a similar extent.
However, caffeine increased the selectivity of the MHS but
not the normal A-site for Ca2 over Mg2 (Table 2).
DISCUSSION
In agreement with previous reports (Mickelson et al., 1988;
Shomer et al., 1993; Herrmann-Frank et al., 1996), [3H]ry-
anodine binding to SR from pigs with the Arg6153Cys
RyR1 MHS mutation was more sensitive to Ca2 activation
and less sensitive to Ca2 inhibition than SR from normal
individuals (Fig. 3; Table 1). An increased sensitivity of
Ca2 activation has also been reported for SR isolated from
individuals with the RyR1 Gly24343Arg human MH mu-
tation (Richter et al., 1997) as well as individuals with
positive MH contracture tests but unknown and probably
variable genotypes (Valdivia et al., 1991). Therefore, we
conclude that the porcine Arg6153Cys mutation, its human
homolog, and likely other MH mutations as well, increase
the sensitivity of the RyR1 to activation by Ca2 and
decrease the sensitivity of the RyR1 to inhibition by Ca2.
Consistent with Mickelson et al. (1990), we found that
Mg2 is a less effective inhibitor of [3H]ryanodine binding
to MHS than to normal SR (Fig. 4). Mg2 has also been
shown to be less effective at inhibiting MHS RyR1 channel
opening (Laver et al., 1997b) and Ca2 release in mechan-
ically peeled MHS muscle fibers (Owen et al., 1997).
Because Mg2 competes with Ca2 for binding to the
two divalent cation regulatory sites on RyR1, and the extent
of Mg2 inhibition at each site is dependent on the Ca2
concentration (Figs. 5 and 6), the relative magnitude of the
Mg2 effect at each site has been difficult to assess. This is
of particular importance as it relates to the molecular basis
of MH, as it is now clear that RyR1 channels with the
Arg6153Cys mutation are more sensitive to activation by
Ca2 and less sensitive to inhibition by both Ca2 and
Mg2. Although the decreased sensitivity of the MHS
RyR1 to inhibition by Mg2 has been extensively studied, it
has not been clear whether the decreased inhibition of the
MHS RyR1 by Mg2 is due solely to a decreased affinity of
FIGURE 6 Ca2 dependence of [3H]ryanodine binding to normal and
MHS SR in the presence or absence of various concentrations of Mg2.
[3H]Ryanodine binding to normal (A) and MHS (B) skeletal muscle SR
was determined as described in Materials and Methods. Media contained
100 mM KCl, 10 mM HEPES (pH 7.4), and 2 mM EGTA. The concen-
trations of MgCl2 and CaCl2 were adjusted to maintain an ionized Mg2
concentration of either 0 mM (E, F), 0.1 mM (, f) or 0.5 mM (‚, Œ)
and Ca2 as indicated in the figure. Data are expressed as percentages of
the maximal [3H]ryanodine binding capacity of the SR vesicle prepara-
tions; solid lines are based on fits to Eq. 5 (see Materials and Methods) and
the parameters presented in Table 1. Data for 0 Mg2 (E, F) are replotted
from Fig. 1 for comparison with 0.1 and 0.5 mMMg2. Means SEM are
of five to seven independent experiments performed in duplicate (five to
seven different SR vesicle preparations).
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the MHS RyR1 I-site for Mg2 or whether alterations in the
affinity of the MHS RyR1 A-site for divalent cations also
plays a role. Either an increase in the affinity of the A-site
for Ca2, or a decreased affinity of the A-site for Mg2
would enhance the ability of Ca2 to compete with Mg2
for the A-site and activate the RyR1. We show here that in
addition to a decreased affinity of the MHS RyR1 I-site for
Mg2, alterations in the MHS RyR1 A-site contribute to the
decreased Mg2 inhibition; i.e., both an increased Ca2
affinity and a decreased Mg2 affinity of the MHS RyR1
A-site contribute to the decreased Mg2 inhibition of the
MHS RyR1.
Although the increased sensitivity of MHS skeletal mus-
cle to caffeine-induced contracture is integral to the clinical
diagnosis of MH (Jurkatt-Rott et al., 2000), the mechanistic
basis for the differential response of normal and MHS
muscle to caffeine has been unclear (Shomer et al., 1994;
Herrmann-Frank et al., 1996). Shomer et al. (1994) reported
no difference in the apparent affinity of the MHS and
normal RyR1 for caffeine and suggested the increased caf-
feine sensitivity of MHS muscle may be due to an increased
resting myoplasmic Ca2 concentration and/or alterations in
the Ca2 affinity of the RyR1. Recent measurements of
intracellular Ca2 in MHS skeletal muscle fibers are con-
sistent with the former hypothesis (Lopez et al., 2000).
However, the effects of caffeine on the Ca2 and Mg2
affinity of normal and MHS RyR1 have not been thoroughly
examined. The data presented suggest that the increased
Ca2 affinity of the MHS RyR1 A-site does indeed con-
tribute to the increased caffeine sensitivity of MHS skeletal
muscle. Because caffeine increased the Ca2 affinity of the
A-site of both the normal and MHS RyR1 to a similar extent
(3–4-fold) the Ca2 affinity of the MHS RyR1 A-site
remained significantly higher than the normal RyR1 A-site
(Table 1). This alone could increase the sensitivity of MHS
skeletal muscle to caffeine-induced contraction. However,
because the extent of the caffeine-induced increase in the
affinity of the normal RyR1 A-site for Ca2 and Mg2 were
similar, the selectivity of the A-site for Ca2 over Mg2 did
not change. In contrast, caffeine did not alter the affinity of
the MHS A-site for Mg2; thus, caffeine further increased
the selectivity of the MHS A-site for Ca2 over Mg2
(Table 2). Thus, both an increased Ca2 affinity of the MHS
RyR1 A-site and a greater selectivity of the MHS A-site for
Ca2 over Mg2 contribute to the enhanced caffeine sensi-
tivity of MHS skeletal muscle.
The extent of RyR1 channel activation reflects the prod-
uct of the fraction of channels with Ca2 bound to the A-site
(fA) and the fraction of channels with the I-site free of both
Ca2 and Mg2 (1  fI). Mg2 shifts the Ca2 dependence
of fA to higher Ca2 concentrations, and decreases 1  fI at
all Ca2 concentrations (Murayama et al., 2000). Conse-
quently, Mg2 decreases the maximal Ca2 activation of
the RyR1 and shifts the Ca2 dependence of activation to
higher Ca2 concentrations (see Fig. 8. of Murayama et al.,
2000). The Arg6153Cys RyR1 mutation opposes the ef-
fects of Mg2 on RyR1. Thus, in a manner similar to
caffeine, in the presence of Mg2, the MH mutation shifted
the Ca2 dependence of fA to lower Ca2 concentrations
(Fig. 1). However, in contrast to caffeine, at low Ca2
concentrations, the MH mutation also increased 1  fI (Fig.
1). As a result, maximal Ca2 activation of the MHS RyR1
is increased and the Ca2 dependence of activation is
shifted to lower Ca2 concentrations compared with the
normal RyR1.
The concentration of free Mg2 present in the myoplasm
is sufficient to inhibit activation of the RyR1 by Ca2 in
intact muscle (Endo, 1977). Indeed, based on the parameters
given in Table 1, and using Eqs. 1 and 2, at a resting Ca2
concentration of 0.1 M and 1 mM Mg2 (Konishi, 1998)
the I-sites of normal and MHS RyR1 are predicted to be
partially occupied (86% and 72%, respectively) by Mg2.
Mg2 is predicted to occupy 99% of the A-sites of both
normal and MHS RyR1. Thus, at physiological levels of
Mg2 both MHS and normal RyR1 channels can be par-
tially activated (15% and 30%, respectively) by increas-
ing the Ca2 concentration. If the channels are to be max-
imally activated, the Mg2 inhibition at the I-site must be
removed. At the same time, Ca2 must replace Mg2 oc-
cupying the A-site. However, the resting myoplasmic Ca2
concentration is not sufficient to activate RyR1 channel
opening. Therefore, if maximal SR Ca2 release is to occur,
the Ca2 sensitivity of the RyR1 A-site must be increased
concurrent with the removal of the Mg2-dependent inhi-
bition of the RyR1. The increased Ca2 affinity of the
A-site could depend in part on other endogenous effectors
of the RyR1, such as ATP (Meissner, 1994) and calmodulin
(Fruen et al., 2000), or alternatively on the interaction of the
RyR1 with the dihydropyridine receptor.
The single point mutation in the porcine MHS RyR1
results in an increased sensitivity of the muscle to voltage
activation (Gallant et al., 1982; Dietze et al., 2000). Al-
though the mechanism by which this occurs is unclear,
Dietze et al. (2000) suggested the MHS mutation alters the
equilibrium for a voltage-independent transition of the
RyR1 from the closed to the open state. The association of
the increased voltage sensitivity of MHS SR Ca2 release
with the enhanced sensitivity of the MHS RyR1 to activa-
tion by Ca2 raises the possibility that endogenous effectors
may modulate the voltage-independent transition. Thus, the
3.5-fold increase in the selectivity of the MHS RyR1 A-site
(KA,Mg/KA,Ca, Table 2) for Ca2 over Mg2 might provide
the basis for the enhanced sensitivity of MHS muscle to
voltage activation.
The Arg6153Cys mutation likely alters the affinity of the
A- and I-sites via a conformational change transmitted over
a significant distance because the mutation is a substantial
distance along the primary sequence from putative locations
of the A- (near amino acid 3885 of RyR3) (Chen et al.,
1998) and I-sites (between amino acids 3726 and 5037) of
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RyR1 (Du and MacLennan, 1999). The proposal that Arg615
is not located in either of the RyR1 Ca2/Mg2-binding
sites is supported by the observation that the human MH
mutation, Gly24343Arg, has a similar effect on the Ca2
sensitivity of activation and inhibition of the RyR1 (Richter
et al., 1997). Although it is difficult to envision how resi-
dues 615 and 2434 could form part of both the high- and
low-affinity Ca2-binding sites, the mechanism by which
these and other MH mutations alter RyR1 function will
remain a matter of speculation until the relationship of the
primary sequence to the tertiary structure of the RyR1 is
resolved in detail.
In summary, we have determined the Ca2 and Mg2
affinities of the A- and I-sites of both the MHS and normal
RyR1. Although the I-site displayed no preference for Ca2
over Mg2, the affinity of the MHS RyR1 I-site for these
ions was reduced nearly twofold compared with the normal
RyR1. The A-site of the normal RyR1, however, had 75-
fold higher affinity for Ca2 compared with Mg2, whereas
the MHS A-site had more than a 250-fold greater preference
for Ca2 over Mg2. This significant increase in Ca2
selectivity over Mg2 may contribute not only to the in-
creased voltage sensitivity of MHS skeletal muscle but also
to the increased sensitivity of MHS muscle to caffeine and
other pharmacological activators.
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